These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 708023)

  • 1. Nafcillin therapy for Staphylococcus aureus endocarditis.
    Masur H; Murray HW; Roberts RB
    Antimicrob Agents Chemother; 1978 Sep; 14(3):457-61. PubMed ID: 708023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA; Courtney KB
    J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study.
    Korzeniowski O; Sande MA
    Ann Intern Med; 1982 Oct; 97(4):496-503. PubMed ID: 6751182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditis.
    Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1979 May; 15(5):735-7. PubMed ID: 525991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
    Chambers HF; Sande MA
    Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions to methicillin and nafcillin during treatment of serious Staphylococcus aureaus infections.
    Kancir LM; Tuazon CU; Cardella TA; Sheagren JN
    Arch Intern Med; 1978 Jun; 138(6):909-11. PubMed ID: 646562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
    Fernandez-Guerrero M; Rouse M; Henry N; Wilson W
    Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants.
    Miller MH; Wexler MA; Steigbigel NH
    Antimicrob Agents Chemother; 1978 Sep; 14(3):336-43. PubMed ID: 251069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.
    Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1980 Oct; 18(4):562-5. PubMed ID: 7447418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.
    Levine DP; Cushing RD; Jui J; Brown WJ
    Ann Intern Med; 1982 Sep; 97(3):330-8. PubMed ID: 7114630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of therapies for Staphylococcus aureus endocarditis.
    Gentry CA; Rodvold KA; Novak RM; Hershow RC; Naderer OJ
    Pharmacotherapy; 1997; 17(5):990-7. PubMed ID: 9324187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.
    Chambers HF; Miller RT; Newman MD
    Ann Intern Med; 1988 Oct; 109(8):619-24. PubMed ID: 3421575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits.
    Egert J; Carrizosa J; Kaye D; Kobasa WD
    J Lab Clin Med; 1977 Jun; 89(6):1262-8. PubMed ID: 864305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A general survey of antibiotic treatment of staphylococcal septicaemia and endocarditis.
    Watanakunakorn C
    Scand J Infect Dis Suppl; 1983; 41():151-7. PubMed ID: 6589752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus.
    Washburn RG; Durack DT
    J Infect Dis; 1981 Sep; 144(3):237-43. PubMed ID: 6268715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections.
    Miller MA; Fish DN; Barber GR; Barron MA; Goolsby TA; Moine P; Mueller SW
    J Microbiol Immunol Infect; 2020 Apr; 53(2):321-327. PubMed ID: 30190234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nafcillin-tolerant Staphylococcus epidermidis endocarditis.
    Arthur JD; Bass JW; Keiser JF; Harden LB; Brown SL
    JAMA; 1982 Jan 22-29; 247(4):487-8. PubMed ID: 6915109
    [No Abstract]   [Full Text] [Related]  

  • 18. Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbits.
    Fass RJ
    J Infect Dis; 1984 Jun; 149(6):904-12. PubMed ID: 6736681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.
    Scheld WM; Keeley JM
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():65-78. PubMed ID: 6421794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users.
    Small PM; Chambers HF
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1227-31. PubMed ID: 2393284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.